Author: gperg1

GPER G-1 is an ABQid Balloon Pitch Finalist!

GPER G-1 Development Group has been chosen as a finalist to present at the 2020 ABQid Balloon Pitch competition on October 2nd, 2020. The highly renowned Balloon Pitch opportunity brings New Mexico’s top high-growth startups together with investor judges from multiple states representing over $150m in investable capital. Click here for a direct link to […]

GPER G-1 Development Group receives STTR Grant for the Development of an Innovative Diabetes Therapeutic Targeting GPER

GPER-1 Development Group LLC has licensed the promising technology from the University of New Mexico and New Mexico State University  PRESS RELEASE: JULY 15, 2020Albuquerque, NM – GPER G-1 Development Group, a portfolio company of the New Mexico Start-Up Factory, is developing a novel therapeutic for the treatment of diabetes and obesity.  The company’s leading drug candidate for the […]

GPER G-1 Technology is Published in Renowned Medical Journal

We are proud to announce that the novel technology licensed by GPER G-1 Development Group, a New Mexico Start-Up Factory II Portfolio Company, has recently been published by Science Translational Medicine and the American Association for the Advancement of Science (AAAS). GPER-G-1 is a drug development company with the primary goal of advancing novel drug candidates […]